6th Oct 2014 15:19
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said a group of executives acquired shares and American Depositary Shares, at a price of 1414.00 pence per share and USD45.90 per ADS, following the re-investment of dividends paid on Shares and ADSs held in the GlaxoSmithKline Deferred Annual Bonus Plan.
Details are as follows.
Director/PDMR |
Number of Ordinary Shares acquired under the personal contribution element of the plan |
Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution) |
Sir Andrew Witty |
1,994 |
1,994 |
Mr S Dingemans |
877 |
877 |
Mr S M Bicknell |
199 |
199 |
Mr R G Connor |
224 |
224 |
Mr S A Hussain |
113 |
113 |
Mr D S Redfern |
426 |
426 |
Ms C Thomas |
322 |
322 |
Mr P C Thomson |
65 |
65 |
Dr P J T Vallance |
935 |
935 |
Ms E Walmsley |
516 |
516 |
Director/PDMR |
Number of ADSs acquired under the personal contribution element of the plan |
Number of ADSs acquired under the matching element of the plan (GSK contribution) |
Dr M M Slaoui |
816 |
816 |
Mrs D P Connelly |
157 |
157 |
Mr W C Louv |
197 |
197 |
Mr D E Troy |
361 |
361 |
The stock was trading at 1,433.89 pence, up 0.6% late Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline